China Isotope & Radiation Corporation
Research China Isotope & Radiation Corporation (1763.HK) on Bullrun: market cap HKD 3.90B, P/E 11.2, dividend yield 2.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker1763.HK
- ExchangeHK
- CountryChina
- SectorHealthcare
- IndustryMedical Devices
- CurrencyHKD
- Market capHKD 3.90B
- P/E11.2
- Dividend yield2.9%
- Financial periodFY2025
- RevenueCNY 7.19B
- Revenue growth-5.1%
- Net incomeCNY 327.43M
- Free cash flowCNY 538.34M
- Gross margin50.4%
Valuation Snapshot
latest market cap is HKD 3.90B; P/E is 11.2; dividend yield is 2.9%.
Peer valuation comparison
Latest P/E is 11.18x versus a Healthcare sector median of 21.74x (48.6% below).
Latest dividend yield is 2.86% versus a Healthcare sector median of 2.4% (19.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 7.19B | CNY 327.43M | CNY 538.34M | 50.4% | 1.02 | CNY 2.56B | CNY 2.73B | CNY 5.23B |
| FY2024 | CNY 7.57B | CNY 406.65M | CNY 142.48M | 48.6% | 1.27 | CNY 2.63B | CNY 2.57B | CNY 5.01B |
| FY2023 | CNY 6.63B | CNY 370.97M | CNY 84.96M | 52.5% | 1.16 | CNY 2.87B | CNY 1.70B | CNY 4.69B |
| FY2022 | CNY 6.15B | CNY 392.28M | CNY 863.12M | 57.2% | 1.23 | CNY 2.93B | CNY 903.86M | CNY 4.47B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 3.90B | 11.2 | 2.9% | 0.35 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.35 HKD, yield 2.9%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.43 CNY |
| FY2024 | 0.42 CNY |
| FY2023 | 0.48 CNY |
| FY2022 | 0.44 CNY |
| FY2021 | 0.22 CNY |
About China Isotope & Radiation Corporation
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of nuclides, diagnostic, and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. The company operates through five segments: Nuclear Medicines; Radioactive Source Products; Irradiation; Nuclear Medical Equipment and Related Services; and Other Businesses.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is China Isotope & Radiation Corporation's market cap?
China Isotope & Radiation Corporation's market capitalization is HKD 3.90B.
What is China Isotope & Radiation Corporation's P/E ratio?
China Isotope & Radiation Corporation's price-to-earnings (P/E) ratio is 11.2.
Does China Isotope & Radiation Corporation pay a dividend?
China Isotope & Radiation Corporation has a dividend yield of 2.9%.
What does China Isotope & Radiation Corporation do?
China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of nuclides, diagnostic, and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. The company operates through five segments: Nuclear Medicines; Radioactive Source Products; Irradiation; Nuclear Medical Equipment and Related Services; and Other Businesses.